We are live on ! Find out more
LNAI

Lunai Bioworks
LNAI

51 hedge funds and large institutions have $7.64M invested in Lunai Bioworks in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 9

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

19% more funds holding

Funds holding: 43 → 51 (+8)

0.03% more ownership

Funds ownership: 0.06% → 0.09% (+0.03%)

42% less call options, than puts

Call options by funds: $384K | Put options by funds: $666K

64% less capital invested

Capital invested by funds: $21.5M → $7.64M (-$13.8M)

Holders
51
Holders Change
+8
Holders Change %
+18.6%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
17
Reduced
9
Closed
14
Calls
$384K
Puts
$666K
Net Calls
-$282K
Net Calls Change
-$490K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.9M
2
State Street
State Street
Massachusetts
+$1.51M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.08M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$962K
5
Nuveen
Nuveen
North Carolina
+$784K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$1.14M
2
Goldman Sachs
Goldman Sachs
New York
-$684K
3
Millennium Management
Millennium Management
New York
-$644K
4
Invesco
Invesco
Georgia
-$629K
5
UCFA
United Capital Financial Advisors
Texas
-$588K

LNAI Hedge Fund Activity: Q2 2022 in Review

51 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2022, worth a combined $7.64M — down 64% from $21.5M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new LNAI positions and 14 closed out — a net gain of 9 holders — while 17 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $4.9M. The largest seller was Vanguard Group, cutting an estimated $1.14M.

  • 51 institutional investors held Lunai Bioworks (LNAI) as of Q2 2022, up from 43 in Q1 2022.
  • Funds reported $7.64M of Lunai Bioworks stock for Q2 2022, down 64% quarter-over-quarter.
  • 23 funds opened new Lunai Bioworks positions in Q2 2022 and 14 closed out, a net change of +9 holders.
  • The largest Lunai Bioworks buyer in Q2 2022 was BlackRock, an estimated $4.9M added.
  • The largest Lunai Bioworks seller in Q2 2022 was Vanguard Group, an estimated $1.14M sold.

Based on aggregated 13F filings for Q2 2022.